A recent report on Natural Killer Cells Therapeutics Market provides a detailed analysis of the industry size, revenue forecasts and geographical landscape pertaining to this business space. Additionally, the report highlights primary obstacles and the latest growth trends accepted by key players that form a part of the competitive spectrum of this business.
Natural Killer Cells Therapeutics Market Size
Global Natural Killer Cells Therapeutics Market is valued at USD 1.94 Billion in 2020 and expected to reach USD 5.92 Billion by 2027 with a CAGR of 17.28% over the forecast period.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.com/requestSample/PostId/1596
Scope of Natural Killer Cells Therapeutics Market
Natural killer (NK) cells are lymphocytes of the innate immune system. NK cells constitute the human body’s frontline defense system as they controls different types of tumors and microbial infections by inhibiting their spread and tissue damage. NK cells have cytotoxicity against tumor cells. According to a recent research study, NK cell biology have paved the way for new therapeutic strategies based on NK cells for the treatment of various cancers as they can target just the cancerous cells and allows the immune system to kill tumors with minimal side effects. Treatment includes the enhancement of antibody dependent cellular cytotoxicity, the manipulation of receptor mediated activation, inclusion criteria based on killer cell immunoglobulin like receptor legend mismatches and adoptive immunotherapy with ex vivo expanded chimeric antigen receptor car engineered or modified NK cells. NK cells are expected to be revolutionary cellular medicines for the treatment of malignancies.
Covid-19 has affected the growth of the global natural killer cells therapeutics market. It is majorly used in the treatment of cancer but due to this pandemic situation, many healthcare services have been delayed globally which has affected the global natural killer cells therapeutics market. However, according to University Of Central Florida (UCF) in October 2020; natural killer cell therapy is in trials for treating COVID-19 as therapy stimulates the body’s natural killer (NK) cells with nanoparticles to increase their numbers and killing ability which may provide an opportunity for its growth in the coming period.
The regions covered in this global NK cells therapeutics market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of global NK cells therapeutics is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
Natural Killer Cells Therapeutics Companies
The major key players of global natural killer cells therapeutics market are
- AltorBioscience Corporation
- PersonGen BioTherapeutics
- Surface Oncology
- ZIOPHARM Oncology
- Five Prime Therapeutics Nohla Therapeutic
- iCell Gene Therapeutics
- Fortress Biotech
- Avid Biotic Corporation
- Sorrento Therapeutics
- Multimmune GmbH
- Innate Pharma and others.
Request for Methodology @ https://brandessenceresearch.com/requestMethodology/PostId/1596
Natural Killer Cells Therapeutics News:
Glycostem’s Launched FDA Approved Onkord Orphan Drug for Multiple Myeloma
On October 16th, 2020, Glycostem Therapeutics, a leading clinical-stage company, announced for treatment of Multiple Myeloma (MM) patients with its investigational product oNKord. Company received the FDA’s Orphan Drug Designation (ODD). It will provide incentives, like eligibility for 7 years of market exclusivity and clear FDA guidance on specific aspects of development for rare diseases. As onkord is a cell based therapy consisting of NK cells. These cells are part of innate or inborn immune system and they particularly target tumor cells while leaving healthy tissues largely untouched which lowers the risk of potentially lethal graft versus host disease due to which transplanted cells view the patients body as foreign and attack it. Onkord is shelf Natural Killer (NK) cellular immunotherapy product launched by Glycostem. In coming days, AML patients will receive this treatment as part of a phase I-IIa (pivotal) trial in AML. A second trial for MM patients is expected to start in 2021. Because of this, Glycostem will become one of the frontrunners in this promising field of cellular immunotherapy.
Increasing Prevalence of Cancer Cases and Rising Adoption of Natural Killer Cells for the Treatment of Liver as Well as Infectious Diseases are Driving the Growth of the Market.
Factors like increase in prevalence of cancer cases, rise in utilization of natural killer cells for the treatment of liver as well as infectious diseases and growing awareness of immunotherapy’s are driving the growth of the market. Increasing cases of cancers are also supplementing the market growth. For example; according to National Cancer Institute; in 2020, 1,806,590 new cancer cases were estimated in United States. As NK cells has property to eliminate immunosuppressive immune cells in the tumor, which helps to treat the cancer. In addition, there are number of infectious diseases are spreading all over the world such as chicken pox, HIV AIDS, tuberculosis, Covid-19, measles and others. For instance; according to WHO, it is estimates that in 2019, 10 million cases of TB worldwide. With 5.6 million men, 3.2 million women and 1.2 million children Also, According to World Health Organization, in 2021, there are 157,289,118 confirmed cases of covid-19, including 3,277,272 deaths. These infectious diseases are spreading through bacteria, viruses, fungi or some parasites. Sometimes these organisms are not harmful but sometimes it might cause deaths. As NK cells have antibacterial effects against intracellular bacterial pathogens which can kill the infected cells. Hence, rising adoption of natural killer cells for the treatment of liver as well as infectious diseases is also propelling the growth of the market.
However, unfavorable effects of NK cells therapeutics may hinder the growth of global NK cells therapeutics market. In spite of that, investment in research and development by government or by different organization can consequently offer more opportunities for the further growth of the market.
Key Benefits of Global Natural Killer Cells Therapeutics Market:
- Global natural killer cells therapeutics Market report covers in-depth historical and forecast analysis.
- Global natural killer cells therapeutics Market research report provides detail information about Market Introduction, Market Summary, Global market, Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
- Global natural killer cells therapeutics Market report helps to identify opportunities in Marketplace.
- Global natural killer cells therapeutics Market report covers extensive analysis of emerging Trends.
Complete Report Details @ https://brandessenceresearch.com/biotechnology/natural-killer-cells-therapeutics-market
Global natural killer cells therapeutics market is segmented on the basis of the basis of type, applications end users and regional and country level. On the basis of type, global NK cells therapeutics market is classified into NK cell therapies and Nk cell directed antibodies. On the basis of disease, global NK cells therapeutics market is classified into cancer, immune proliferative disorder. On the basis of end-users, global NK cells therapeutics market is classified into hospitals and research centres.
Global Natural Killer Cells Therapeutics Market Segmentation:
- Nk Cell Therapies
- Nk Cell Directed Antibodies
- Immune Proliferative Disorder
- Research Centers
By Regional & Country Analysis: (North America, U.S., Canada, Europe, U.K., France, Germany, Italy,Asia Pacific, China, Japan, India, Southeast Asia, Latin America, Brazil, Mexico, Middle East and Africa, GCC, Africa, Rest of Middle East and Africa)
Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global Natural Killer Cells Therapeutics Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Natural Killer Cells Therapeutics Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Natural Killer Cells Therapeutics Market: Trends
2.8. Porter’s Five Forces Analysis
2.9. Market Attractiveness Analysis
3. Chapter – Global Natural Killer Cells Therapeutics Market Overview: Quantitative Analysis
4. Chapter – Global Natural Killer Cells Therapeutics Market Analysis: Segmentation By Type
5. Chapter – Global Natural Killer Cells Therapeutics Market Analysis: Segmentation By Application
About Us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at email@example.com
Other Related Report:
Acrylonitrile Butadiene Styrene (ABS) Market Size: Acrylonitrile Butadiene Styrene market size, was worth of USD 27.45 Billion in 2020 and is expected to reach USD 46.88 Billion by 2027, growing at a CAGR of 6.92% from 2020 to 2027. The global Acrylonitrile Butadiene Styrene market is expected to grow at significant growth rate due to number of driving factor.
Formaldehyde Market Size: Formaldehyde Market is valued at USD 20.79 Billion in 2020 and expected to reach USD 28.58 Billion by 2027 with the CAGR of 4.65% over the forecast period.